As of February 2023 Moderna has a market cap of $66.55 Billion. This makes Moderna the world's 223th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $66.55 B | -3.55% |
2022 | $69.00 B | -32.99% |
2021 | $102.97 B | 149.1% |
2020 | $41.33 B | 528.01% |
2019 | $6.58 B | 31.11% |
2018 | $5.02 B |
On Feb 5th, 2023 the market cap of Moderna was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $430.36 B | 546.60% | ๐บ๐ธ USA |
![]() Novartis NVS | $181.96 B | 173.39% | ๐จ๐ญ Switzerland |
![]() Merck MRK | $260.99 B | 292.12% | ๐บ๐ธ USA |
![]() Regulus Therapeutics RGLS | $27.11 M | -99.96% | ๐บ๐ธ USA |
![]() Dicerna Pharmaceuticals DRNA | $2.97 B | -95.53% | ๐บ๐ธ USA |
![]() Athersys ATHX | $29.25 M | -99.96% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | $28.71 B | -56.86% | ๐บ๐ธ USA |
![]() Arrowhead Pharmaceuticals
ARWR | $3.92 B | -94.11% | ๐บ๐ธ USA |